IRDI

IRDI Gestion is a regional investment capital firm with a focus on fostering economic growth and job creation in the Southwest of France. With over 35 years of experience, they manage €150 million and offer financial support to SMEs in various stages of development, ranging from creation to transmission. Through a partnership approach, IRDI Gestion works closely with companies to provide equity ranging from €100,000 to €5,000,000. The group comprises three SCR entities: IRDI, MPcroissance, and IRDInov, each dedicated to supporting industrial growth, small businesses, and innovative startups, respectively. Approved by the AMF in 2015, IRDI Gestion is committed to structuring the group and driving new development projects to support the regional economy.

Jean-Michel Petit

Investment Director

42 past transactions

REEV

Seed Round in 2025
REEV is focused on enhancing the mobility of individuals with walking disorders by creating intelligent wearable robotics. These motorized orthosis devices are designed to be lightweight and personalized, providing intuitive support that helps users walk, stand, sit, and navigate stairs with confidence. By diminishing muscle fatigue and facilitating daily movements, REEV aims to improve the quality of life for its users, allowing them to regain autonomy and independence in their everyday activities. The company’s mission is rooted in the belief that everyone, regardless of their level of disability or age, deserves the opportunity to enjoy their mobility fully.

Starfish Bioscience

Seed Round in 2024
Starfish Bioscience specializes in developing biotechnological systems for agriculture and viticulture. Its primary focus is regenerating soil health by restoring microbiomes, enhancing sustainability and crop yields, while minimizing environmental impact.

Micropep

Series B in 2024
Micropep Technologies is an agricultural biotechnology company founded in 2016 and based in Toulouse, France. The company specializes in the development of non-GMO bioherbicides and biostimulants utilizing its innovative miPEP technology, which harnesses naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep focuses on four key development programs: germination, flowering, growth, and weed control, aiming to improve agricultural yields while maintaining the integrity of plant DNA. By leveraging the potential of these biomimetic peptides, Micropep seeks to provide effective solutions for managing plant genetics and enhancing resistance to diseases, thereby supporting sustainable farming practices.

REEV

Seed Round in 2023
REEV is focused on enhancing the mobility of individuals with walking disorders by creating intelligent wearable robotics. These motorized orthosis devices are designed to be lightweight and personalized, providing intuitive support that helps users walk, stand, sit, and navigate stairs with confidence. By diminishing muscle fatigue and facilitating daily movements, REEV aims to improve the quality of life for its users, allowing them to regain autonomy and independence in their everyday activities. The company’s mission is rooted in the belief that everyone, regardless of their level of disability or age, deserves the opportunity to enjoy their mobility fully.

Ascendance

Venture Round in 2023
Founded in 2018 by four ex-Airbus engineers: Jean-Christophe Lambert, Thibault Baldivia, Clément Dinel and Benoît Ferran, Ascendance is an industrial start-up with a mission to decarbonise aviation. Based in the heart of Toulouse, the European capital of aviation, it has developed and markets two products: an innovative hybrid-electric propulsion system ‘Sterna’, and a hybrid-electic vertical take-off and landing (VTOL) aircraft powered by Sterna technology, ‘Atea’.

Poclain Hydraulics

Private Equity Round in 2022
Poclain Hydraulics is a global industrial company specializing in the design, manufacture, and sale of hydrostatic transmissions. With expertise renowned worldwide, they serve diverse markets such as agriculture, construction, material handling, industry, and environmental sectors.

Micropep

Series A in 2022
Micropep Technologies is an agricultural biotechnology company founded in 2016 and based in Toulouse, France. The company specializes in the development of non-GMO bioherbicides and biostimulants utilizing its innovative miPEP technology, which harnesses naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep focuses on four key development programs: germination, flowering, growth, and weed control, aiming to improve agricultural yields while maintaining the integrity of plant DNA. By leveraging the potential of these biomimetic peptides, Micropep seeks to provide effective solutions for managing plant genetics and enhancing resistance to diseases, thereby supporting sustainable farming practices.

Mon Chasseur Immo

Venture Round in 2022
Mon Chasseur Immo is a French real estate agency that helps buyers search, visit, and purchase properties across major French cities, including Paris, Bordeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Strasbourg, Toulouse, and Aix-en-Provence. It provides targeted property visits, online project tracking, personalized support for real estate projects, and assistance with price negotiations and financing through a property search platform that enables buyers to communicate directly with property owners and make offers in a transparent process. Founded in 2012 and based in Montpellier, the company operates additional offices in Paris, Lyon and Bordeaux to support its national activity.

Eldo

Venture Round in 2022
Eldo supports professionals and brands in the home improvement sector in the digitalization of their communication, commercial management.

SeqOne Genomics

Series A in 2022
SeqOne S.A.S. is a company based in Montpellier, France, that specializes in developing genomic data analysis software for the healthcare industry. Founded in 2017, SeqOne's platform offers end-to-end management of next-generation sequencing (NGS) and bioinformatics data, providing advanced tools for analyzing complex genomic information. The software is designed to deliver medically actionable results across various areas, including oncology, hematological diseases, rare diseases, genetic screening, and hereditary conditions. By addressing the challenges associated with analyzing rich genomic data, SeqOne aims to enhance the accessibility and effectiveness of genomic medicine, thereby facilitating improved treatment options for patients. The company serves both private and public healthcare sectors, contributing to the ongoing transformation of healthcare through the integration of genomic insights.

Neurinnov

Seed Round in 2021
Neurinnov is a developer and manufacturer of advanced neurostimulation solutions aimed at improving the quality of life for patients with severe spinal cord injuries. The company specializes in active implantable medical devices designed to treat quadriplegic individuals whose muscles are paralyzed yet can be stimulated. Neurinnov's innovative technology selectively activates specific muscles by directing electrical currents through targeted nerve fibers, allowing patients to regain essential hand grasping functions and increasing their autonomy. By minimizing undesirable effects, the company's devices effectively restore grip-in-hand functionality, offering new hope to those affected by paralysis.

Ascendance

Venture Round in 2021
Founded in 2018 by four ex-Airbus engineers: Jean-Christophe Lambert, Thibault Baldivia, Clément Dinel and Benoît Ferran, Ascendance is an industrial start-up with a mission to decarbonise aviation. Based in the heart of Toulouse, the European capital of aviation, it has developed and markets two products: an innovative hybrid-electric propulsion system ‘Sterna’, and a hybrid-electic vertical take-off and landing (VTOL) aircraft powered by Sterna technology, ‘Atea’.

Micropep

Series A in 2021
Micropep Technologies is an agricultural biotechnology company founded in 2016 and based in Toulouse, France. The company specializes in the development of non-GMO bioherbicides and biostimulants utilizing its innovative miPEP technology, which harnesses naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep focuses on four key development programs: germination, flowering, growth, and weed control, aiming to improve agricultural yields while maintaining the integrity of plant DNA. By leveraging the potential of these biomimetic peptides, Micropep seeks to provide effective solutions for managing plant genetics and enhancing resistance to diseases, thereby supporting sustainable farming practices.

Fineheart

Series B in 2021
Fineheart is a France-based medical device company specializing in innovative technologies for cardiovascular care. It focuses on the development of implantable cardiac devices aimed at treating cardiovascular diseases. The company's flagship product is a novel, wirelessly powered, fully implantable mechanical circulatory support device. This device is designed to optimize cardiac output while preserving the heart's natural contractility, thereby enabling patients to restore normal cardiac function. Fineheart's technology aims to improve the quality of life for heart failure patients, allowing them to return to normal daily activities.

SmartCatch

Venture Round in 2021
SmartCatch specializes in liquid biopsy technology aimed at enhancing cancer detection and treatment. The company has developed a minimally invasive method to extract circulating tumor cells, offering a series of products focused on the capture and isolation of these cells. This technology provides researchers and clinicians with valuable data that can significantly improve cancer patient outcomes. By empowering the medical community with advanced tools, SmartCatch contributes to the ongoing battle against cancer, facilitating better diagnostic and therapeutic approaches.

PeopleSpheres

Venture Round in 2021
PeopleSpheres is a Paris-based company that specializes in providing a comprehensive human resources information system (HRIS) software solution designed to meet the diverse needs of businesses. Founded in 2010 and originally named NeoSpheres SAS, the company rebranded to PeopleSpheres in September 2019. The software solution offered by PeopleSpheres is tailored to be suitable, sustainable, and scalable, addressing the specific challenges faced by organizations in HR management. To enhance its offerings, PeopleSpheres collaborates with leading national HR service providers, particularly targeting American businesses. As of September 2019, PeopleSpheres operates as a subsidiary of Sopra HR Software SAS, further solidifying its position in the HR technology space.

Les Nouvelles Fermes

Seed Round in 2021
Les Nouvelles Fermes is a sustainable agricultural company that specializes in the production of fruits, vegetables, herbs, and fish using innovative aquaponics methods. The firm emphasizes the cultivation of produce in a closed-loop system, integrating fish farming to naturally fertilize crops, thereby eliminating the need for pesticides and antibiotics. Committed to ultra-local and inclusive agriculture, Les Nouvelles Fermes aims to provide fresh, high-quality products while promoting responsible and water-efficient farming practices. By bridging the gap between market gardening, agro-industry, and emerging startups, the company advocates for a new model of agriculture that prioritizes environmental sustainability and consumer health.

AcuSurgical

Series A in 2021
AcuSurgical is a startup focused on advancing vitreo-retinal surgery through innovative technology. The company is developing a robotic surgical assistant specifically designed for retinal microsurgery, which aims to enhance the precision of eye operations. By providing surgeons with improved tools, AcuSurgical's device addresses common challenges faced in the treatment of retinal diseases, such as age-related macular degeneration. The technology helps filter hand tremors and enhances visualization during procedures, ultimately enabling better patient outcomes in the field of ophthalmic surgery.

Appvizer

Series A in 2020
Appvizer is a software comparison platform that assists businesses in selecting the right applications to enhance productivity. It features a comprehensive database of over 10,000 software packages across 506 categories, including CRM, payroll, and accounting solutions. Primarily focusing on Software as a Service (SaaS) offerings, Appvizer enables users to access cloud-hosted applications without the need for installation, thereby eliminating concerns related to maintenance, updates, and licensing. The platform also provides valuable resources, such as articles and videos, to address common professional challenges and employs machine learning technologies to facilitate users' search for suitable software solutions. Through its services, Appvizer aims to simplify the decision-making process for businesses seeking effective software tools.

EvidenceB

Venture Round in 2020
EvidenceB is a Paris-based software company that develops educational platforms and resources for school curriculums. Its learning platforms deliver adaptive knowledge modules for students and teacher dashboards and tools that support differentiated instruction. The company combines didactics, cognitive science and artificial intelligence to power an evidence-based intelligent tutoring system delivered via software as a service. Its adaptive learning system targets K-12, higher education and professional training, offering curriculum-agnostic designs tailored to specific programs, evidence-based gameplay, and a data-driven AI engine that supports learning analytics, impact measurement and A/B testing. The solution emphasizes deep understanding of core concepts, including for lower-performing students.

Blue Valet

Venture Round in 2018
Blue Valet, founded in 2015 and based in Mérignac, France, specializes in online valet parking services at airports and train stations. The company offers a convenient platform for travelers to book valet services, ensuring a hassle-free experience when accessing major mobility hubs. Blue Valet aims to provide an economical and efficient solution for both leisure and business travelers, allowing them to navigate their journeys without stress or complications.

Oncrawl

Venture Round in 2018
OnCrawl is a technical SEO platform specializing in enterprise SEO audits and daily monitoring. The company assists over a thousand clients across 66 countries in enhancing their organic traffic, rankings, and revenues by providing insights into Google's algorithms. Clients include major corporations such as Vistaprint, Canon, Lastminute.com, and Forbes. OnCrawl is known for its data-driven approach, offering actionable dashboards and reports that support the entire SEO process. The company has secured two successful funding rounds and has been recognized with multiple awards, including the Best SEO Tool award at the European Search Awards for three consecutive years and the Best Search Software Tool at the US Search Awards in 2019.

Vaonis

Seed Round in 2018
Founded in 2016, Vaonis specializes in manufacturing innovative telescopes. Its flagship product, Stellina, is a portable, user-friendly telescope that can be connected to smartphones for easy observation and photography of the night sky.

BackBone

Angel Round in 2017
BackBone specializes in the creation, production and marketing of movement preservation solutions for the treatment of spinal pathologies which affects more than 40% of the world population.BackBone is supported by the best spine surgeons and professionals in the industry to launch its first implant (LISA) for lumbar pathologies.

Advicenne

Private Equity Round in 2017
Advicenne is a late-stage biopharmaceutical company established in 2007 and headquartered in Nîmes, France. It focuses on developing and commercializing innovative treatments for unmet medical needs in nephrology, particularly for orphan renal diseases and niche neurology indications. The company's lead drug candidate, ADV7103, is currently undergoing late-stage clinical trials for two specific conditions: distal renal tubular acidosis (dRTA) and cystinuria. Advicenne aims to create pediatric-friendly therapeutics that enhance the quality of life for patients from early childhood through adulthood.

Ixaltis

Venture Round in 2016
Ixaltis is a pharmaceutical company focused on developing therapeutics for genitourinary disorders that have unmet medical needs. Founded by a team of experts in urology and pharmaceuticals, including Dr. Philippe Lluel and Christian Chavy, Ixaltis aims to identify and repurpose drugs that have already reached clinical stages for use in treating genitourinary tract diseases. The company has established a proprietary position with its lead product, Litoxetine, which operates through a specific mechanism of action to address various urogenital disorders. By leveraging its expertise, Ixaltis seeks to improve urinary continence and enhance the quality of life for patients suffering from these conditions.

Fineheart

Series A in 2016
Fineheart is a France-based medical device company specializing in innovative technologies for cardiovascular care. It focuses on the development of implantable cardiac devices aimed at treating cardiovascular diseases. The company's flagship product is a novel, wirelessly powered, fully implantable mechanical circulatory support device. This device is designed to optimize cardiac output while preserving the heart's natural contractility, thereby enabling patients to restore normal cardiac function. Fineheart's technology aims to improve the quality of life for heart failure patients, allowing them to return to normal daily activities.

Cacolac

Venture Round in 2015
Cacolac is a manufacturer specializing in food bars, chocolate drinks, and flavored milk. The company is particularly known for its chocolate milk drink, which combines cocoa with fresh milk to deliver a product that is both flavorful and competitively priced. Cacolac focuses on quality and taste, aiming to provide consumers with enjoyable beverage options.

Groupe Ermic Developpement

Private Equity Round in 2014
Groupe Ermic Developpement has design and manufacture of microcomputer, electronic, electrical, and mechanical equipment.

LNC Therapeutics

Series B in 2012
LNC Therapeutics is a biopharmaceutical company focused on developing innovative drugs that target the gut microbiota to treat obesity and associated cardiometabolic diseases. The company's pipeline encompasses fundamental research, preclinical studies, and clinical trials, aiming to bring a next-generation approach to these health challenges. Backed by prominent venture capital investors and family offices, LNC Therapeutics has raised €16.5 million to date, including €1.5 million in grants from French BPI and the Aquitaine Region. The company collaborates globally with renowned medical experts to ensure high standards in its drug development process.

ABIONYX Pharma

Series C in 2010
ABIONYX Pharma SA is a French biopharmaceutical company established in 2005, currently based in Labege. It specializes in the discovery and development of therapies targeting high-density lipoprotein (HDL) for treating cardiovascular and metabolic diseases. The company's primary focus is on developing HDL mimetics to rapidly regress atherosclerotic plaque in high-risk patients. Its lead product candidate, CER-001, is a Phase II clinical trial asset designed to mimic the properties of pre-beta HDL for treating post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients. Additionally, ABIONYX Pharma has another drug candidate, CER-209, in Phase I trials for metabolic diseases and liver-related conditions such as atherosclerosis and non-alcoholic steato-hepatitis.

AT Internet

Venture Round in 2009
AT Internet is one of the French Internet’s early pioneers. After two decades of existence, AT Internet is the only European company today among the worldwide leaders in digital analytics and digital intelligence. AT Internet’s Analytics Suite is used on more than 20,000 websites, mobile sites, and mobile apps globally. We count amongst our customers some of the world’s largest media groups (BBC, NPO, Schibsted, RTE, Le Monde…), banks (AXA, Société Générale, Crédit Agricole…) and have partnered with certain clients for more than a decade. Our unique approach to digital analytics is different from other solutions on the market. Having data you can trust is a mandatory foundation for any analytics project you undertake. That’s why our Analytics Suite features tools for easy quality control and dependable tagging for fully reliable data. Our solution and processes are completely compliant with stringent privacy laws (notably the European GDPR) and are certified by third-party auditors worldwide.

Neosens

Series B in 2009
Neosens SA is a company focused on designing and developing advanced sensor solutions and technologies for monitoring and controlling the quality of water and industrial liquids. Established in 2001 and headquartered in Labege, France, Neosens specializes in microelectronic sensors that measure dissolved oxygen levels and monitor fouling in various liquid environments. Its products find applications in diverse sectors, including cooling systems, heat exchangers, potable and ultra-pure water, industrial boilers, and industries such as food and beverage, pharmaceuticals, pulp and paper, oil, gas, and petrochemicals. Neosens aims to enhance environmental monitoring and process efficiency through its innovative sensor technologies.

Leyio

Series A in 2009
Leyio is a technology company based in Gradignan, France, that specializes in the development of communicative electronic products. Founded in 2008, Leyio produces personal sharing devices designed for the seamless exchange of digital files, such as photographs, videos, music, and work documents, without the need for a computer. These devices incorporate advanced security features, including fingerprint scanning, to protect users' information. Leyio's innovative approach to mobile file sharing has led to collaborations with notable clients in the tech industry, including Sony and Toshiba, as it aims to enhance the way individuals carry and share digital content.

Exakis

Series C in 2009
Exakis designs and develops software solutions for communications as well as Internet applications. The company’s products also assist in e-business, B2B, and intranet services. Exakis also provides consulting as well as software integration services. The company is based in Bidart, France with offices in Paris, Nantes, Lyon, and Bordeaux.

LDL Technology

Series B in 2008
LDL Technology is a privately owned company that specializes in the development, manufacture, and marketing of wireless embedded electronic systems. Founded in 2004 and headquartered in Toulouse, France, the company operates in France, Japan, and the United States. Its product offerings include tire pressure monitoring systems, vehicle immobilizer systems, keyless entry and start systems, and body control units. These technologies are employed in various applications, including motorcycles, buses, trucks, mass transit systems, inflatable boats, and subway systems. LDL Technology primarily caters to the original equipment manufacturer market, providing innovative solutions to enhance vehicle safety and convenience.

Noomeo

Venture Round in 2008
Noomeo is a pioneering company established in 2007, focused on providing innovative 3D scanning solutions for businesses seeking user-friendly and portable systems. The company specializes in non-contact 3D digitization, enabling companies to integrate this technology into their processes efficiently and cost-effectively. Noomeo's commitment to research and development, in collaboration with esteemed research institutions, allows it to continually enhance its offerings. The company has developed advanced hardware solutions, known as OptiNum, and accompanying software, called NumiSoft, which automate the creation of 3D mock-ups. Through these innovations, Noomeo positions itself as a leader in the field of 3D digitization, catering to the evolving needs of various industries.

Neosens

Venture Round in 2008
Neosens SA is a company focused on designing and developing advanced sensor solutions and technologies for monitoring and controlling the quality of water and industrial liquids. Established in 2001 and headquartered in Labege, France, Neosens specializes in microelectronic sensors that measure dissolved oxygen levels and monitor fouling in various liquid environments. Its products find applications in diverse sectors, including cooling systems, heat exchangers, potable and ultra-pure water, industrial boilers, and industries such as food and beverage, pharmaceuticals, pulp and paper, oil, gas, and petrochemicals. Neosens aims to enhance environmental monitoring and process efficiency through its innovative sensor technologies.

Seanodes

Series B in 2007
Seanodes SA develops data storage domain and shared internal storage solutions in France. It offers Exanodes, a software solution, which creates a shared storage system using the cluster's own hard disks. The company’s technology virtualizes storage assets to leverage underused internal disks and direct attached storage into a virtual shared storage array. It also provides online support, implementation, and consulting services. The company serves small and medium businesses, service providers, high performance computing, government, life sciences, manufacturing, media and entertainment, and oil and gas sectors through a network of resellers internationally. Seanodes SA was founded in 2002 and is based in Boulogne Billancourt, France.

PraXcell

Venture Round in 2006
PraXcell is created in 2003. The company's principal activity is the development of advanced tools for cellular therapy. These are the human stem cells and the medical devices.

LDL Technology

Series A in 2005
LDL Technology is a privately owned company that specializes in the development, manufacture, and marketing of wireless embedded electronic systems. Founded in 2004 and headquartered in Toulouse, France, the company operates in France, Japan, and the United States. Its product offerings include tire pressure monitoring systems, vehicle immobilizer systems, keyless entry and start systems, and body control units. These technologies are employed in various applications, including motorcycles, buses, trucks, mass transit systems, inflatable boats, and subway systems. LDL Technology primarily caters to the original equipment manufacturer market, providing innovative solutions to enhance vehicle safety and convenience.

Seanodes

Series A in 2004
Seanodes SA develops data storage domain and shared internal storage solutions in France. It offers Exanodes, a software solution, which creates a shared storage system using the cluster's own hard disks. The company’s technology virtualizes storage assets to leverage underused internal disks and direct attached storage into a virtual shared storage array. It also provides online support, implementation, and consulting services. The company serves small and medium businesses, service providers, high performance computing, government, life sciences, manufacturing, media and entertainment, and oil and gas sectors through a network of resellers internationally. Seanodes SA was founded in 2002 and is based in Boulogne Billancourt, France.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.